BioSpace News Archive

NeuBase Therapeutics, Inc. (Nasdaq: NBSE) (“NeuBase” or the “Company”), a biotechnology company accelerating the genetic revolution using a new class of precision genetic medicines, today announced positive new data and program updates for its development pipeline of PATrOL-enabled genetic medicines.

Movano Inc. is set to join the Russell Microcap® Index at the conclusion of the 2021 Russell indexes annual reconstitution, effective after the US market opens on June 28, according to a preliminary list of additions posted June 4.

SHINE Medical Technologies LLC today announced that it has entered a multi-year contract with the University of Missouri Research Reactor, or MURR®, for irradiation of ytterbium-176, the starting material for the production of lutetium-177 (Lu-177), a therapeutic isotope showing great promise for improving patient outcomes for a range of cancers.

Amyotrophic lateral sclerosis (ALS) is a severe, fatal neurodegenerative disorder causing loss of motor neurons and voluntary muscle action

Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa”), today announced that the U.S Patent and Trademark Office issued a patent covering methods of using ARCALYST® (rilonacept) in the treatment of recurrent pericarditis.

SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the limited commercial launch of its 3D-printed WaveForm L (Lateral) Interbody System.

TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX) announced that the complete results of the OCS™ Liver PROTECT Trial (“PROTECT”) were presented virtually at the American Transplant Congress on Tuesday June 8th, 2021.

Elite Pharmaceuticals, Inc., a specialty pharmaceutical company developing niche generic products, announced that it will release its 2021 year-end financial results on Monday, June 14, 2021.

Capital Raise Expected to Extend Runway Through Late 2022 and Allow Additional Milestones for a Potential NDA Filing for Nyxol in Reversal of Mydriasis

Thermo Fisher Scientific Inc. announced that Marc N. Casper , chairman, president and chief executive officer, will present virtually at the Goldman Sachs 42 nd Annual Global Healthcare Conference on Thursday, June 10, 2021 at 9:40 a.m. (EDT) .